Clinical trial

The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations

NCT00303303 · Wake Forest University Health Sciences, Other · Terminated

Key facts

NCT number NCT00303303
Title The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations
Official title The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations
Lead sponsor Wake Forest University Health Sciences, Other
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Snake Envenomation
Intervention type Biological
Interventions Crotaline Polyvalent Immune Fab (ovine) (active initial and maintenance therapy), Crotaline Immune Fab (ovine) (active initial therapy, placebo maintenance therapy), Placebo
Enrollment 13
Start date Apr 1, 2005
Primary completion May 1, 2008
Completion May 1, 2008
First posted Mar 16, 2006
Last update posted Dec 1, 2023
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies